Healio
Healio

Sitemap

January 29, 2007 Articles

Filter by Available Specialty

Filter by specialty

  1. Bioptigen receives FDA premarket approval for new OCT system
  2. Differences in low-vision questionnaire administration can affect scores
  3. Genentech letter: Increased stroke risk with 0.5-mg dose in Lucentis SAILOR study
  4. New RA drug shows efficacy over methotrexate alone in phase 3 trial
  5. Study finds high risk of pseudoexfoliation syndrome converting to glaucoma